• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病肾病和2型糖尿病患者肠道微生物群的组成改变

Compositional Alterations of Gut Microbiota in Patients with Diabetic Kidney Disease and Type 2 Diabetes Mellitus.

作者信息

He Xin, Sun Jiping, Liu Chao, Yu Xiaoyang, Li Huixian, Zhang Wenjing, Li Yan, Geng Yingzhou, Wang Zhigang

机构信息

Dialysis Department of Nephrology Hospital, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, People's Republic of China.

Department of Nephrology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, People's Republic of China.

出版信息

Diabetes Metab Syndr Obes. 2022 Mar 6;15:755-765. doi: 10.2147/DMSO.S347805. eCollection 2022.

DOI:10.2147/DMSO.S347805
PMID:35280499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8911313/
Abstract

PURPOSE

Emerging evidence has revealed that gut microbiota plays a pivotal role in the pathogenesis of type 2 diabetes mellitus (TDM) and diabetic kidney disease (DKD). However, few studies have used metagenomic sequencing to analyze the alterations of gut microbiota community in patients with early-stage DKD.

METHODS

We carried out metagenomic sequencing in fecal samples of 10 DKD patients (DKD group) and 10 TDM patients who appeared to be less prone to DKD (non-DKD group), aiming to compare the composition and function of gut microbiota between the DKD and non-DKD groups.

RESULTS

The gut microbial community of the DKD group was significantly different from that of the non-DKD group, characterized by a marked increase in phylum Proteobacteria, genus , species, unclassified, and . The amounts of species and were significantly and positively correlated with the urinary albumin creatinine ratio in the DKD group. Furthermore, functional analysis based on dbCAN and KEGG databases showed aberrant lipopolysaccharide (LPS) biosynthesis and carbohydrate metabolism in the gut microbiome of the DKD group.

CONCLUSION

Our findings provided evidence for alterations in the composition and function of gut microbiota in patients with DKD versus the non-DKD group. These data may contribute to a more comprehensive understanding of the pathological mechanisms of DKD.

摘要

目的

新出现的证据表明,肠道微生物群在2型糖尿病(TDM)和糖尿病肾病(DKD)的发病机制中起关键作用。然而,很少有研究使用宏基因组测序来分析早期DKD患者肠道微生物群群落的变化。

方法

我们对10例DKD患者(DKD组)和10例似乎不太容易发生DKD的TDM患者(非DKD组)的粪便样本进行了宏基因组测序,旨在比较DKD组和非DKD组之间肠道微生物群的组成和功能。

结果

DKD组的肠道微生物群落与非DKD组显著不同,其特征是变形菌门、属、种、未分类和的显著增加。DKD组中种和的数量与尿白蛋白肌酐比值呈显著正相关。此外,基于dbCAN和KEGG数据库的功能分析显示,DKD组肠道微生物群中脂多糖(LPS)生物合成和碳水化合物代谢异常。

结论

我们的研究结果为DKD患者与非DKD组相比肠道微生物群的组成和功能变化提供了证据。这些数据可能有助于更全面地了解DKD的病理机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ff/8911313/850d0deb085f/DMSO-15-755-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ff/8911313/00bb2ea3201e/DMSO-15-755-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ff/8911313/bff23262cbce/DMSO-15-755-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ff/8911313/32c65583eca4/DMSO-15-755-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ff/8911313/d6f692891596/DMSO-15-755-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ff/8911313/c03eeb673151/DMSO-15-755-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ff/8911313/850d0deb085f/DMSO-15-755-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ff/8911313/00bb2ea3201e/DMSO-15-755-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ff/8911313/bff23262cbce/DMSO-15-755-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ff/8911313/32c65583eca4/DMSO-15-755-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ff/8911313/d6f692891596/DMSO-15-755-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ff/8911313/c03eeb673151/DMSO-15-755-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ff/8911313/850d0deb085f/DMSO-15-755-g0006.jpg

相似文献

1
Compositional Alterations of Gut Microbiota in Patients with Diabetic Kidney Disease and Type 2 Diabetes Mellitus.糖尿病肾病和2型糖尿病患者肠道微生物群的组成改变
Diabetes Metab Syndr Obes. 2022 Mar 6;15:755-765. doi: 10.2147/DMSO.S347805. eCollection 2022.
2
A systematic review and meta-analysis of gut microbiota in diabetic kidney disease: Comparisons with diabetes mellitus, non-diabetic kidney disease, and healthy individuals.糖尿病肾病患者肠道微生物组的系统评价和荟萃分析:与糖尿病、非糖尿病肾病和健康个体的比较。
Front Endocrinol (Lausanne). 2022 Oct 20;13:1018093. doi: 10.3389/fendo.2022.1018093. eCollection 2022.
3
The Specific Alteration of Gut Microbiota in Diabetic Kidney Diseases-A Systematic Review and Meta-Analysis.糖尿病肾病中肠道微生物组的特定改变——系统评价和荟萃分析。
Front Immunol. 2022 Jun 17;13:908219. doi: 10.3389/fimmu.2022.908219. eCollection 2022.
4
The Intestinal Microbiota Composition in Early and Late Stages of Diabetic Kidney Disease.糖尿病肾病早晚期的肠道微生物组成。
Microbiol Spectr. 2023 Aug 17;11(4):e0038223. doi: 10.1128/spectrum.00382-23. Epub 2023 Jun 21.
5
The harmful intestinal microbial community accumulates during DKD exacerbation and microbiome-metabolome combined validation in a mouse model.在小鼠模型中,DKD 恶化时有害的肠道微生物群落积累,微生物组-代谢组联合验证。
Front Endocrinol (Lausanne). 2022 Dec 19;13:964389. doi: 10.3389/fendo.2022.964389. eCollection 2022.
6
Gut microbiota diversity in middle-aged and elderly patients with end-stage diabetic kidney disease.终末期糖尿病肾病中老年患者的肠道微生物群多样性
Ann Transl Med. 2022 Jul;10(13):750. doi: 10.21037/atm-22-2926.
7
Gut microbiota and its metabolites - molecular mechanisms and management strategies in diabetic kidney disease.肠道微生物群及其代谢物 - 糖尿病肾病的分子机制和管理策略。
Front Immunol. 2023 Jan 19;14:1124704. doi: 10.3389/fimmu.2023.1124704. eCollection 2023.
8
Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice.沙库巴曲缬沙坦可改善糖尿病肾病,并调节小鼠肠道微生物群。
Front Endocrinol (Lausanne). 2022 Dec 16;13:1034818. doi: 10.3389/fendo.2022.1034818. eCollection 2022.
9
Alterations of the Gut Microbiota in Multiple System Atrophy Patients.多系统萎缩患者肠道微生物群的改变
Front Neurosci. 2019 Oct 18;13:1102. doi: 10.3389/fnins.2019.01102. eCollection 2019.
10
The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease.肠道微生物群和微生物群相关血清代谢产物在糖尿病肾病进展中的作用
Front Pharmacol. 2021 Nov 24;12:757508. doi: 10.3389/fphar.2021.757508. eCollection 2021.

引用本文的文献

1
Gut Microbiota and Metabolites: Biomarkers and Therapeutic Targets for Diabetes Mellitus and Its Complications.肠道微生物群与代谢产物:糖尿病及其并发症的生物标志物和治疗靶点
Nutrients. 2025 Aug 11;17(16):2603. doi: 10.3390/nu17162603.
2
Metagenomic profiling of gut microbime: associating their role with the advancement of diabetic nephropathy.肠道微生物群的宏基因组分析:将它们的作用与糖尿病肾病的进展相关联。
Antonie Van Leeuwenhoek. 2025 Aug 22;118(9):135. doi: 10.1007/s10482-025-02141-5.
3
Multi-omics analysis reveals the efficacy of two probiotic strains in managing feline chronic kidney disease through gut microbiome and host metabolome.

本文引用的文献

1
Focus on the Gut-Kidney Axis in Health and Disease.关注健康与疾病中的肠-肾轴。
Front Med (Lausanne). 2021 Jan 21;7:620102. doi: 10.3389/fmed.2020.620102. eCollection 2020.
2
Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.肠道微生物群作为肥胖和 2 型糖尿病代谢性炎症的触发因素。
Front Immunol. 2020 Oct 16;11:571731. doi: 10.3389/fimmu.2020.571731. eCollection 2020.
3
An Almond-Based Low Carbohydrate Diet Improves Depression and Glycometabolism in Patients with Type 2 Diabetes through Modulating Gut Microbiota and GLP-1: A Randomized Controlled Trial.
多组学分析揭示了两种益生菌菌株通过肠道微生物群和宿主代谢组来管理猫慢性肾病的功效。
Front Vet Sci. 2025 Jun 18;12:1590388. doi: 10.3389/fvets.2025.1590388. eCollection 2025.
4
Gut Microbiota and Their Metabolites: The Hidden Driver of Diabetic Nephropathy? Unveiling Gut Microbe's Role in DN.肠道微生物群及其代谢产物:糖尿病肾病的隐藏驱动因素?揭示肠道微生物在糖尿病肾病中的作用。
J Diabetes. 2025 Apr;17(4):e70068. doi: 10.1111/1753-0407.70068.
5
The gut microbiota and diabetic nephropathy: an observational study review and bidirectional Mendelian randomization study.肠道微生物群与糖尿病肾病:一项观察性研究综述及双向孟德尔随机化研究
Trials. 2025 Mar 24;26(1):101. doi: 10.1186/s13063-025-08755-4.
6
Alterations of the gut microbiota in patients with diabetic nephropathy and its association with the renin-angiotensin system.糖尿病肾病患者肠道微生物群的改变及其与肾素-血管紧张素系统的关联。
J Diabetes Metab Disord. 2025 Feb 20;24(1):69. doi: 10.1007/s40200-025-01579-8. eCollection 2025 Jun.
7
Characteristics of tongue coating microbiota in diabetic and non-diabetic kidney patients receiving hemodialysis.接受血液透析的糖尿病和非糖尿病肾病患者舌苔微生物群的特征
BMC Oral Health. 2025 Jan 20;25(1):104. doi: 10.1186/s12903-025-05455-y.
8
Regulation of intestinal flora by extract ameliorates hyperglycemia in a mouse model of type 2 diabetes mellitus.提取物对肠道菌群的调节改善了2型糖尿病小鼠模型的高血糖状况。
Front Nutr. 2024 Dec 16;11:1499196. doi: 10.3389/fnut.2024.1499196. eCollection 2024.
9
Causal Relationships Between Gut Microbiota, Metabolites, and Diabetic Nephropathy: Insights from a Two-Sample Mendelian Randomization Analysis.肠道微生物群、代谢物与糖尿病肾病之间的因果关系:来自两样本孟德尔随机化分析的见解
Int J Nephrol Renovasc Dis. 2024 Dec 10;17:319-332. doi: 10.2147/IJNRD.S489074. eCollection 2024.
10
enhances HS production in .增强. 中的 HS 产生。
Gut Microbes. 2024 Jan-Dec;16(1):2431644. doi: 10.1080/19490976.2024.2431644. Epub 2024 Nov 28.
基于杏仁的低碳水化合物饮食通过调节肠道菌群和 GLP-1 改善 2 型糖尿病患者的抑郁和糖代谢:一项随机对照试验。
Nutrients. 2020 Oct 3;12(10):3036. doi: 10.3390/nu12103036.
4
Gut Microbiota and Cardiovascular Disease.肠道微生物群与心血管疾病。
Circ Res. 2020 Jul 31;127(4):553-570. doi: 10.1161/CIRCRESAHA.120.316242. Epub 2020 Jul 30.
5
Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A.膳食纤维通过短链脂肪酸介导的 G 蛋白偶联受体 GPR43 和 GPR109A 的激活来预防糖尿病肾病。
J Am Soc Nephrol. 2020 Jun;31(6):1267-1281. doi: 10.1681/ASN.2019101029. Epub 2020 May 1.
6
The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的痰微生物组、气道炎症与死亡率。
J Allergy Clin Immunol. 2021 Jan;147(1):158-167. doi: 10.1016/j.jaci.2020.02.040. Epub 2020 Apr 28.
7
Clinical update: The important role of dual kidney function testing (ACR and eGFR) in primary care: Identification of risk and management in type 2 diabetes.临床更新:双肾功能检测(ACR 和 eGFR)在初级保健中的重要作用:2 型糖尿病的风险识别和管理。
Prim Care Diabetes. 2020 Aug;14(4):370-375. doi: 10.1016/j.pcd.2020.02.006. Epub 2020 Mar 2.
8
Role of gut microbiota in type 2 diabetes pathophysiology.肠道微生物群在 2 型糖尿病发病机制中的作用。
EBioMedicine. 2020 Jan;51:102590. doi: 10.1016/j.ebiom.2019.11.051. Epub 2020 Jan 3.
9
A sea cucumber (Holothuria leucospilota) polysaccharide improves the gut microbiome to alleviate the symptoms of type 2 diabetes mellitus in Goto-Kakizaki rats.海参(糙海参)多糖通过改善肠道微生物组缓解 Goto-Kakizaki 大鼠 2 型糖尿病症状。
Food Chem Toxicol. 2020 Jan;135:110886. doi: 10.1016/j.fct.2019.110886. Epub 2019 Oct 16.
10
Antioxidant, Anti-Inflammatory, and Metabolic Properties of Tocopherols and Tocotrienols: Clinical Implications for Vitamin E Supplementation in Diabetic Kidney Disease.生育酚和三烯生育酚的抗氧化、抗炎和代谢特性:维生素 E 补充剂在糖尿病肾病中的临床意义。
Int J Mol Sci. 2019 Oct 15;20(20):5101. doi: 10.3390/ijms20205101.